Sarah Oughtred is recorded as CFO at FIGS, Inc. (FIGS). The newest filing on record that lists Sarah Oughtred as CFO at FIGS, Inc. (FIGS) is dated April 23, 2026. FIGS, Inc. reported in an 8-K filed June 12, 2024 that Sarah Oughtred was appointed Chief Financial Officer, effective August 9, 2024. The proxy statement of FIGS, Inc. reports total compensation of $2,637,314 for Sarah Oughtred in fiscal 2025, including a base salary of $502,874. Disclosed compensation is on record for 2 fiscal years. Sarah Oughtred has spoken on 6 earnings calls and 2 other investor events across 1 company, most recently for FIGS, Inc. on September 8, 2026. FIGS, Inc. is classified in the Apparel Manufacturing industry within the Consumer Cyclical sector. Other leadership on record at FIGS, Inc. includes Catherine Spear (CEO and Board Member), Heather Hasson (Chairman), Kevin Fosty (Chief Accounting Officer) and 7 others.
“On June 7, 2024, the Board of Directors (the "Board") of FIGS, Inc. (the "Company") appointed Sarah Oughtred to serve as the Company's Chief Financial Officer, effective as of August 9, 2024 (the "Effective Date"), succeeding Kevin Fosty, who has been serving in the role on an interim basis while the Company engaged in a search process for a permanent Chief Financial Officer.”
“So, you know, we've been growing the business. We've been accelerating that growth rate, and a big piece of that is from higher traffic. We've seen great efforts from all over our marketing channels that are driving that traffic and still maintaining strong conversion.”
“Our second quarter results were outstanding from top to bottom, building up a great Q1 with across-the-board wins and setting us up for a stronger second half of the year than our implied prior guide.”
“You know, keep in mind that we are a different business today, and we've made some really incredible shifts to continue to reach healthcare professionals. And so, you know, we've made shifts to expand our business globally.”
“Our better-than-planned first quarter results continued the powerful narrative coming out of 2025, where we strengthened the foundation of our business and advanced our work to scale our strategic pillars across product innovation, community engagement, and market expansion.”
“Our year-to-date performance highlights the growing potential of the fig story as we more closely align our product strategy with our unique ability to drive impact for healthcare professionals.”
